Dana Farber Cancer Institue — Boston, Massachusetts

Dana Farber Cancer Institue is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institue has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Multiple Myeloma, Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Recurrence.

Sponsors: Stemline Therapeutics, Inc., Arsenal Biosciences, Inc., Aprea Therapeutics.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institue?

Dana Farber Cancer Institue has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institue conducted?

Dana Farber Cancer Institue has 5 clinical trials on record, with 3 currently active. Their work covers Multiple Myeloma, Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Recurrence.

Is Dana Farber Cancer Institue accredited by Crixeo Health?

Dana Farber Cancer Institue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institue?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.